company background image
538964 logo

Mercury Laboratories BSE:538964 Stock Report

Last Price

₹1.08k

Market Cap

₹1.3b

7D

5.7%

1Y

33.6%

Updated

09 Sep, 2024

Data

Company Financials

Mercury Laboratories Limited

BSE:538964 Stock Report

Market Cap: ₹1.3b

538964 Stock Overview

Develops, manufactures, markets, distributes, and sells pharmaceutical drugs, medicines, and formulations for mother and child healthcare in South East Asia, Africa, Latin America, and internationally.

538964 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends3/6

Mercury Laboratories Limited Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Mercury Laboratories
Historical stock prices
Current Share Price₹1,082.45
52 Week High₹1,303.00
52 Week Low₹709.00
Beta0.34
11 Month Change7.51%
3 Month Change26.60%
1 Year Change33.64%
33 Year Change56.19%
5 Year Change314.33%
Change since IPO3,231.64%

Recent News & Updates

Recent updates

Shareholder Returns

538964IN PharmaceuticalsIN Market
7D5.7%0.5%-1.0%
1Y33.6%59.3%39.5%

Return vs Industry: 538964 underperformed the Indian Pharmaceuticals industry which returned 59.3% over the past year.

Return vs Market: 538964 underperformed the Indian Market which returned 39.5% over the past year.

Price Volatility

Is 538964's price volatile compared to industry and market?
538964 volatility
538964 Average Weekly Movement5.6%
Pharmaceuticals Industry Average Movement6.1%
Market Average Movement6.3%
10% most volatile stocks in IN Market9.6%
10% least volatile stocks in IN Market3.8%

Stable Share Price: 538964 has not had significant price volatility in the past 3 months.

Volatility Over Time: 538964's weekly volatility (6%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
1962537Rajendra Shahwww.mercurylabs.com

Mercury Laboratories Limited develops, manufactures, markets, distributes, and sells pharmaceutical drugs, medicines, and formulations for mother and child healthcare in South East Asia, Africa, Latin America, and internationally. It offers antihypertensive, PCOS and uterine disorders, galactagogue, haemostat, iron and vitamins, preterm labor management, antiemetic, PPI, zinc supplement, antiallergic, digestive enzyme, promolact, child care, cardiovascular and respiratory system, eye, gastro-intestinal system, analgesics/anti-inflammatory/antipyretic, antibiotic, anti-infective, and other products for gynec, pediatric, surgeon, and physician. The company exports its formulations, such as anti-inflammatory, antimalarial, digestive, hypoglycemic, multivitamin, CNS, pain management, gynec, CVS, cold and cough, miscellaneous, and other formulations, as well as antibiotic, antifungal, and antiviral formulations.

Mercury Laboratories Limited Fundamentals Summary

How do Mercury Laboratories's earnings and revenue compare to its market cap?
538964 fundamental statistics
Market cap₹1.31b
Earnings (TTM)₹49.96m
Revenue (TTM)₹739.14m

26.0x

P/E Ratio

1.8x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
538964 income statement (TTM)
Revenue₹739.14m
Cost of Revenue₹295.83m
Gross Profit₹443.31m
Other Expenses₹393.35m
Earnings₹49.96m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)41.63
Gross Margin59.98%
Net Profit Margin6.76%
Debt/Equity Ratio10.9%

How did 538964 perform over the long term?

See historical performance and comparison

Dividends

0.3%

Current Dividend Yield

7%

Payout Ratio

Does 538964 pay a reliable dividends?

See 538964 dividend history and benchmarks
When do you need to buy 538964 by to receive an upcoming dividend?
Mercury Laboratories dividend dates
Ex Dividend DateSep 20 2024
Dividend Pay DateOct 26 2024
Days until Ex dividend10 days
Days until Dividend pay date46 days

Does 538964 pay a reliable dividends?

See 538964 dividend history and benchmarks